Tag

Cardiovascular Risk

All articles tagged with #cardiovascular risk

health5 days ago•2 min saved

Less-fit individuals must exercise more weekly to gain the same heart benefits, study finds

A UK Biobank study of over 17,000 adults followed for about eight years found that meeting the NHS guideline of 150 minutes per week reduces cardiovascular risk by ~8-9%, but the least fit participants needed about 30-50 extra minutes weekly to achieve the same benefit. Greater risk reductions require even more activity (370 minutes for ~20% risk reduction for least fit vs 340 minutes for most fit; >610 minutes for >30% reduction vs ~560). The findings suggest higher activity levels may be needed for optimal protection, though experts caution against pushing extreme weekly totals; public health guidance remains that 150 minutes is beneficial for all, with more providing added protection.

via The Guardian|

#cardiovascular-risk #exercise #fitness

health10 days ago•7 min saved

Ultra-Processed Foods Linked to Higher Heart Disease Risk, New ESC Consensus Warns

A European Heart Journal consensus from the European Society of Cardiology links high ultra-processed food (UPF) intake with greater risks of heart disease, atrial fibrillation, and cardiovascular death, as well as obesity and diabetes; the authors urge clinicians to ask about UPF consumption, advocate for clearer labeling and stronger regulations, and note that most evidence is observational while long-term trials are needed.

via SciTechDaily|

#cardiovascular-risk #diabetes #health

health12 days ago•4 min saved

Hidden Lipoprotein(a) May Raise Heart Risk Even With Normal Tests

Lp(a) is a genetically determined cholesterol particle linked to higher risk of heart attack and stroke that standard tests miss. Lifestyle and most cholesterol meds don’t meaningfully lower Lp(a); newer gene-silencing therapies show large reductions in Lp(a) in trials and could reduce events if confirmed. Testing is often advised for those with a family history or unexplained risk, but for now heart health still hinges on managing LDL cholesterol, blood pressure, smoking, activity, and diet.

via SciTechDaily|

#cardiovascular-risk #genetics #health

health21 days ago•6 min saved

NIH Trial Analysis Links Lipoprotein(a) to Increased Stroke and Death Risk

A study analyzing stored plasma from 20,070 participants in the ACCORD, PEACE, and SPRINT NIH trials found elevated Lipoprotein(a) levels (>=175 nmol/L) are linked to higher residual cardiovascular risk despite standard therapy: about 31% more major adverse cardiovascular events (MACE), 49% higher cardiovascular death risk, and 64% higher stroke risk, with stronger effects in those with existing heart disease; the level was not linked to a higher risk of heart attack. Testing Lp(a) could guide risk assessment and, as new targeted therapies emerge, drive more aggressive management of cholesterol and other risk factors.

via SciTechDaily|

#cardiovascular-risk #cholesterol #health

health24 days ago•5 min saved

Elevated Lp(a) Signals Ongoing Heart Risk Despite Standard Therapy

A new analysis of 20,070 adults from NIH trials shows very high lipoprotein(a) levels (≥175 nmol/L) are linked to a greater risk of major adverse cardiovascular events—especially stroke and cardiovascular death—and this risk is strongest in people with existing heart disease, suggesting Lp(a) contributes to residual risk even with standard LDL-lowering treatments. No clear increase in heart attack risk was observed. Lp(a) is largely genetic, so testing could help refine risk and guide prevention, with emerging therapies targeting Lp(a) on the horizon.

via Medical News Today|

#cardiovascular-risk #genetics #health

health26 days ago•36 min saved

Tramadol’s limited relief vs. rising risks prompt a rethink of its use for chronic pain

A BMJ Evidence-Based Medicine review analyzed 19 randomized trials (6,506 participants) and found tramadol provides only modest, likely non-meaningful relief for chronic pain while doubling the risk of harm versus placebo—predominantly heart-related events—with common side effects such as nausea, dizziness, and constipation. Many included studies carried biases that may overstate benefits and understate harms; a questionable signal for cancer risk was noted due to short follow-up. Overall, the potential harms appear to outweigh the limited benefits, underscoring a need to rethink tramadol’s role in chronic-pain care amid broader opioid concerns.

via Earth.com|

#adverse-effects #cardiovascular-risk #chronic-pain

health29 days ago•17 min saved

Lower LDL targets push earlier, risk-based heart prevention

Doctors lowered the LDL cholesterol targets and tied them to an individual’s overall cardiovascular risk, enabling earlier, risk-driven prevention. The guidance uses the PREVENT calculator to decide when lifestyle changes suffice versus when medications should begin, with statins remaining first-line and quicker escalation to ezetimibe or injections if needed. The update also recommends testing lipoprotein(a) and apolipoprotein B, considers targeted imaging in uncertain cases, and calls for earlier screening (adults at 19; kids around 9–11) to detect inherited hypercholesterolemia and start prevention before emergencies.

via Earth.com|

#cardiovascular-risk #cholesterol #health

health-and-wellbeing1 month ago•1 min saved

Cholesterol risk isn’t about weight alone—genetics and fat intake matter

High LDL cholesterol raises heart attack and stroke risk, but being lean doesn’t guarantee safety; genetics and saturated-fat intake largely drive LDL levels. Obesity mainly affects other lipids (triglycerides and remnant cholesterol) and is linked to diabetes and high blood pressure, which can make LDL more harmful. Overall cardiovascular risk isn’t determined by LDL alone, so a clinician should assess it—consider NHS checks from age 40 and family history of early heart disease.

via The Guardian|

#cardiovascular-risk #cholesterol #genetics

health1 month ago•7 min saved

ApoB testing could steer cholesterol care toward fewer heart attacks and strokes

A Northwestern-led simulation study finds using apoB levels to guide cholesterol-lowering therapy may prevent more heart attacks and strokes over a lifetime and be cost-effective compared with LDL- or non-HDL-guided strategies, though apoB testing isn’t yet routine due to extra testing, cost, and current guideline adoption.

via Medical News Today|

#apob #cardiovascular-risk #cholesterol-testing

health1 month ago•7 min saved

Consistent Bedtimes Could Shield Your Heart, New Study Suggests

A Finnish study of 3,321 adults finds that irregular bedtimes significantly raise the risk of major cardiovascular events, especially in those sleeping under eight hours, likely due to circadian disruption. The researchers urge maintaining a consistent wake and bedtime, limit evening caffeine/alcohol, and screen exposure to support heart health.

via SELF Magazine|

#bedtime #cardiovascular-risk #circadian-rhythm

health1 month ago•5 min saved

Irregular Bedtimes May Double Midlife Heart Risk

A long-running study of 3,231 adults from Northern Finland found that large swings in bedtime significantly raise the risk of major cardiovascular events (heart attack or stroke), especially for those sleeping less than eight hours. Irregular wake times did not show a clear link. Variability in the sleep midpoint also correlated with higher risk, highlighting the importance of consistent bedtimes and circadian alignment for heart health over a decade of follow-up.

via Neuroscience News|

#cardiovascular-risk #circadian-rhythm #health

health1 month ago•5 min saved

Nine Daily Ultra-Processed Servings Linked to 67% Heart-Risk Rise

A 12-year study of 6,814 U.S. adults found that those averaging about nine servings per day of ultra-processed foods had a 67% higher risk of major cardiovascular events (heart attack, stroke, or related death) than those eating ~1 serving. Risk rose about 5.1% with each additional daily serving. The relationship is observational, not causal, with stronger signals among Black participants. The practical take: limit ultra-processed foods and emphasize whole, minimally processed options, aiming for a Mediterranean-style pattern.

via prevention.com|

#cardiovascular-risk #diet-patterns #health

health-and-medicine1 month ago•8 min saved

New cholesterol guidelines push earlier, personalized heart-disease prevention

The 2026 ACC/AHA dyslipidemia guidelines call for earlier, more personalized cholesterol screening (even in children for familial hypercholesterolemia), broader risk assessment including genetic factors like Lp(a), and introduce a new PREVENT calculator to estimate 10- and 30-year cardiovascular risk, with expanded treatment options and lower LDL targets to prevent heart disease decades down the line.

via ScienceDaily|

#cardiovascular-risk #cholesterol #health-and-medicine

health1 month ago•5 min saved

Tiny daily changes in sleep, activity, and diet cut heart risk significantly

A study of over 50,000 adults followed for about eight years found that small, coordinated changes across sleep, exercise, and diet (SPAN) steadily lower major cardiovascular event risk, with higher SPAN scores linked to greater protection—up to a 50% reduction for the top scorers. Even modest tweaks, like 10 extra minutes of sleep, a bit more daily activity, and minor diet improvements, can yield meaningful risk reductions, suggesting small, sustainable changes may outperform sweeping lifestyle overhauls.

via Medical News Today|

#cardiovascular-risk #diet #health

health2 months ago•266 min saved

Heart protection from GLP-1 drugs fades quickly after stopping, study finds

A Washington University study of more than 333,000 U.S. veterans with type 2 diabetes found that continuous GLP-1 therapy reduced cardiovascular risk by about 18% after three years; stopping the medication for six months raised risk by 4%, after one year by 14%, and after two years by 22%, with restarting yielding only partial protection, highlighting the importance of long‑term use and accompanying lifestyle changes.

via AOL.com|

#bmj-medicine #cardiovascular-risk #glp-1-drugs